Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Ambulatory Oxygen Effects on Muscles in COPD [Phase 4]
This Phase 4 trial from the University of Birmingham studied the effects of ambulatory oxygen on muscle function in people with chronic obst…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
Trial update NCT01649310 investigates whole body vibration as an intervention for chronic obstructive pulmonary disease, with no results or …
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Web-based, Interactive Professional Education for Chronic Obstructive Pulmonary Disease
The trial evaluated a web-based, interactive education program for primary care clinicians regarding chronic obstructive pulmonary disease a…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Pulmonary Disease in Patients Referred for Coronary CT
This entry reports the completion of a clinical trial studying pulmonary disease in patients referred for coronary CT, sponsored by Universi…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial updating results on adding umeclidinium bromide to fluticasone furoate/vilanterol versus placebo added to fluticasone furoate/…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of RV1162 in healthy volunteers and COPD patients, with study stat…
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler
A study update presenting vital status and pulmonary medication usage data for COPD patients who prematurely withdrew from tiotropium inhala…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 trial comparing QMF149 to salmeterol/fluticasone in COPD completed with results posted, assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Long-Term Study of the Effects of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe COPD (MK-7123-019) [Phase 2]
Phase 2 long-term study of navarixin (MK-7123) in moderate to severe COPD was terminated with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial evaluating co-administration of umeclidinium (NVA237) and indacaterol once daily versus indacaterol alone in moderate-to-sever…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients [Phase 4]
This update reports findings from a Phase 4 trial evaluating the acute effect of pulmonary desufflation on cardiac performance in COPD patie…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Improving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (COPD) [NA]
A completed clinical trial focused on improving end-of-life communication for patients with COPD, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial evaluating roflumilast for visceral adiposity and metabolic parameters in chronic obstructive pulmonary disease with metabolic…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: Co-administration of Olodaterol Respimat® and Tiotropium Handihaler® [Phase 3]
A Phase 3 study evaluating the safety and efficacy of co-administering Striverdi Respimat (olodaterol) and Spiriva (tiotropium) HandiHaler i…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
This completed clinical trial evaluated whether the short physical performance battery (SPPB) and 4-meter gait speed can predict hospital re…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Single Ascending Dose Study of TRN-157 in Healthy Subjects [Phase 1]
A Phase 1 single ascending dose study of TRN-157 in healthy subjects has completed; the study evaluated safety, tolerability, and pharmacoki…
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: The Respiratory Physiology Variation of COPD Patients in Inspiratory Muscle Training [Phase 2, Phase 3]
This clinical trial update notes the completion of Phase 2 and Phase 3 studies evaluating inspiratory muscle training in patients with chron…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea [Phase 4]
A Phase 4 clinical trial assessing the effect of indacaterol maleate on lung volume and dyspnea in chronic obstructive pulmonary disease pat…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Effect of Prolonged Decubitus on Nitric Oxide Concentration in Chronic Obstructive Pulmonary Disease [Phase 4]
A Phase 4 clinical trial evaluating the effect of prolonged decubitus on nitric oxide levels in chronic obstructive pulmonary disease has co…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Closing Volume Interpretation and Bronchodilators Effect [Phase 4]
Phase 4 clinical trial update evaluating closing volume interpretation and the effects of bronchodilators.
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Acute Effect of Aclidinium on Hyperinflation and Ventilation Inhomogeneity in Severe COPD Patients [Phase 4]
This Phase 4 study evaluated the acute effects of aclidinium on hyperinflation and ventilation inhomogeneity in patients with severe chronic…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Randomized, Crossover Safety and Pharmacokinetics Study of PT010 [Phase 1]
A Phase 1 randomized, crossover study assessed the safety and pharmacokinetics of PT010 in COPD and has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide [Phase 2]
Phase 2 study evaluating the efficacy and safety of PH-797804 in adults with moderate to severe COPD on a background of tiotropium. The tria…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD) [Phase 2]
Phase 2 safety and tolerability trial update for AZD2423 in patients with moderate to severe chronic obstructive pulmonary disease; the stud…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
AstraZeneca-sponsored Phase 2 trial evaluating oral AZD2423 (100 mg) in adults with mild chronic obstructive pulmonary disease; results were…